Wayne Harris, MD
-
RoleMedical Oncology
-
Research Program
-
Practicing Since1998
Wayne B. Harris, MD, is an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and joined the faculty in 1998. Dr. Harris also serves as the assistant chief of hematology and medical oncology at the Atlanta Veterans Affairs Medical Center. A board certified medical oncologist, he has worked to develop new treatments for kidney cancer, bladder cancer and prostate cancer through clinical trials and translational research at Winship Cancer Institute and the Atlanta Veterans Affairs Medical Center. These include numerous investigator-initiated, cooperative group and industry-sponsored studies.
Dr. Harris obtained his Medical Degree from Loma Linda University in 1988 in southern Calfornia. He subsequently completed three years of specialty training in Internal Medicine at Emory University in Atlanta. After completing a service obligation to the National Health Scholarship Corps in Chattanooga, TN, he returned to Emory where he completed three additional years of subspecialty training in Hematology and Oncology. He is board certified in Medical Oncology.
On a national level, Dr. Harris works as a member of the Core Committee for Genitourinary Oncology of the Eastern Cooperative Oncology Group; American College of Radiology Imaging Network where he has served the principle investigator for national clinical trials. He is also a member of Loma Linda University Health Board of Trustees.
Title/Journal | Authors | Publication Date |
---|---|---|
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
LJ Appleman, SE Kim, WB Harris, SK Pal, MR Pins, J Kolesar, N Agarwal, RA Parikh, DA Vaena, CW Ryan, M Hashmi, BA Costello, D Cella, JP Dutcher, RS DiPaola, NB Haas, LI Wagner, MA Carducci | 06/10/2024 |
Journal of immunotherapy and precision oncology |
DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, EE Hitron, GA Russler, L Yantorni, S Caulfield, JT Brown, JM Goldman, B Nazha, BC Carthon, WB Harris, O Kucuk, VA Master, MA Bilen | 08/01/2022 |
Cancers |
TZ Zhuang, K Case, TA Olsen, JT Brown, BC Carthon, O Kucuk, J Goldman, W Harris, MA Bilen, B Nazha | 06/10/2022 |
Clinical genitourinary cancer |
DJ Martini, ST Evans, Y Liu, JM Shabto, OE Uner, TA Olsen, JT Brown, GA Russler, L Yantorni, S Caulfield, JM Goldman, B Nazha, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen | 02/01/2022 |
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy. Frontiers in endocrinology |
TA Olsen, TZ Zhuang, S Caulfield, DJ Martini, JT Brown, BC Carthon, O Kucuk, W Harris, MA Bilen, B Nazha | 01/01/2022 |
The oncologist |
DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, D Ravindranathan, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, SS Joshi, HT Kissick, KE Ogan, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen | 12/01/2021 |
The oncologist |
DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, WB Harris, HT Kissick, VA Master, O Kucuk, BC Carthon, MA Bilen | 10/01/2021 |
Journal for immunotherapy of cancer |
JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, L Yantorni, SS Joshi, H Kissick, K Ogan, B Nazha, BC Carthon, O Kucuk, WB Harris, VA Master, MA Bilen | 07/01/2021 |
The oncologist |
JT Brown, Y Liu, JM Shabto, DJ Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, LB Yantorni, SS Joshi, H Kissick, K Ogan, WB Harris, BC Carthon, O Kucuk, VA Master, MA Bilen | 05/01/2021 |
Molecular neurobiology |
S Yousuf, F Atif, C Espinosa-Garcia, W Harris, N Turan, DG Stein | 03/01/2021 |
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer treatment and research communications |
DJ Martini, MR Kline, Y Liu, JM Shabto, BC Carthon, GA Russler, L Yantorni, EE Hitron, S Caulfield, JM Goldman, WB Harris, O Kucuk, VA Master, MA Bilen | 01/01/2021 |
Frontiers in oncology |
DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, HT Kissick, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen | 01/01/2021 |
Frontiers in oncology |
TA Olsen, DJ Martini, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, WB Harris, O Kucuk, BC Carthon, VA Master, B Nazha, MA Bilen | 01/01/2021 |
British journal of cancer |
RD Harvey, BC Carthon, C Lewis, MS Hossain, C Zhang, Z Chen, WB Harris, OB Alese, W Shaib, MA Bilen, DH Lawson, C Wu, CE Steuer, BF El-Rayes, FR Khuri, S Lonial, EK Waller, SS Ramalingam, TK Owonikoko | 10/01/2020 |
Clinical cancer research : an official journal of the American Association for Cancer Research |
TK Owonikoko, RD Harvey, B Carthon, Z Chen, C Lewis, H Collins, C Zhang, DH Lawson, OB Alese, MA Bilen, GL Sica, CE Steuer, WL Shaib, C Wu, WB Harris, M Akce, RR Kudchagkar, BF El-Rayes, S Lonial, SS Ramalingam, FR Khuri | 06/01/2020 |
Cancer medicine |
JM Shabto, DJ Martini, Y Liu, D Ravindranathan, J Brown, EE Hitron, GA Russler, S Caulfield, H Kissick, M Alemozaffar, K Ogan, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen | 04/01/2020 |
The oncologist |
DJ Martini, Y Liu, JM Shabto, BC Carthon, EE Hitron, GA Russler, S Caulfield, HT Kissick, WB Harris, O Kucuk, VA Master, MA Bilen | 03/01/2020 |
Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases. Science advances |
S Tan, H Yang, S Xue, J Qiao, M Salarian, K Hekmatyar, Y Meng, R Mukkavilli, F Pu, OY Odubade, W Harris, Y Hai, ML Yushak, VM Morales-Tirado, P Mittal, PZ Sun, D Lawson, HE Grossniklaus, JJ Yang | 02/01/2020 |
Clinical genitourinary cancer |
MA Bilen, GMA Dutcher, Y Liu, D Ravindranathan, HT Kissick, BC Carthon, O Kucuk, WB Harris, VA Master | 06/01/2018 |
Asian journal of urology |
RR Sekar, D Patil, Y Baum, J Pearl, A Bausum, MA Bilen, O Kucuk, WB Harris, BC Carthon, M Alemozaffar, CP Filson, JG Pattaras, PT Nieh, K Ogan, VA Master | 10/01/2017 |
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. Oncogene |
X Guo, JL Koff, AB Moffitt, M Cinar, S Ramachandiran, Z Chen, JM Switchenko, M Mosunjac, SG Neill, KP Mann, M Bagirov, Y Du, Y Natkunam, HJ Khoury, MR Rossi, W Harris, CR Flowers, IS Lossos, LH Boise, SS Dave, J Kowalski, L Bernal-Mizrachi | 07/20/2017 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine |
WB Harris, C Zhang, Y Liu, DK Robertson, MY Akbashev, BM Lingerfelt, O Kucuk, BC Carthon, TW Gillespie, AO Osunkoya, VA Master | 06/01/2017 |
Bone marrow transplantation |
Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller | 01/01/2017 |
Bone marrow transplantation |
Z DeFilipp, M Purcell, WA Harris, DJ Chandra, C Gleason, J Wrammert, S Sarantopoulos, EK Waller | 04/01/2016 |
Oncotarget |
H Yang, CM Brackett, VM Morales-Tirado, Z Li, Q Zhang, MW Wilson, C Benjamin, W Harris, EK Waller, AV Gudkov, LG Burdelya, HE Grossniklaus | 01/19/2016 |
Molecular aspects of medicine |
WB Harris | 11/01/2015 |
C-reactive protein in urologic cancers. Molecular aspects of medicine |
J Huang, Y Baum, M Alemozaffar, K Ogan, W Harris, O Kucuk, VA Master | 11/01/2015 |
Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Archives of biochemistry and biophysics |
K Sahin, B Cross, N Sahin, K Ciccone, S Suleiman, AO Osunkoya, V Master, W Harris, B Carthon, R Mohammad, B Bilir, K Wertz, CS Moreno, CL Walker, O Kucuk | 04/15/2015 |
External validation of the modified Glasgow prognostic score for renal cancer. Indian journal of urology : IJU : journal of the Urological Society of India |
CG Tai, TV Johnson, A Abbasi, L Herrell, WB Harris, O Kucuk, DJ Canter, K Ogan, JG Pattaras, PT Nieh, VA Master | 01/01/2014 |
PloS one |
P Forghani, W Harris, CR Giver, A Mirshafiey, J Galipeau, EK Waller | 01/01/2013 |
Lectins identify glycan biomarkers on glioblastoma-derived cancer stem cells. Stem cells and development |
C Tucker-Burden, P Chappa, M Krishnamoorthy, BA Gerwe, CD Scharer, J Heimburg-Molinaro, W Harris, SN Usta, CD Eilertson, CG Hadjipanayis, SL Stice, DJ Brat, RJ Nash | 09/01/2012 |
International journal of surgical oncology |
BW Cross, TV Johnson, AB Derosa, K Ogan, JG Pattaras, PT Nieh, O Kucuk, WB Harris, VA Master | 01/01/2012 |
Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. The Journal of urology |
TV Johnson, S Ali, A Abbasi, O Kucuk, WB Harris, K Ogan, J Pattaras, PT Nieh, FF Marshall, AO Osunkoya, VA Master | 10/01/2011 |
Journal of immunology (Baltimore, Md. : 1950) |
JM Li, L Southerland, MS Hossain, CR Giver, Y Wang, K Darlak, W Harris, J Waschek, EK Waller | 07/15/2011 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine |
S Ali, Q Yin-Goen, TV Johnson, W Han, NA Johnson, WB Harris, FF Marshall, AN Young, VA Master, AO Osunkoya | 04/01/2011 |
Urology |
TV Johnson, A Abbasi, A Owen-Smith, AN Young, O Kucuk, WB Harris, AO Osunkoya, K Ogan, J Pattaras, PT Nieh, FF Marshall, VA Master | 09/01/2010 |
Journal of immunology (Baltimore, Md. : 1950) |
JM Li, LT Southerland, Y Lu, KA Darlak, CR Giver, DW McMillin, WA Harris, DL Jaye, EK Waller | 12/15/2009 |
American heart journal |
V Subramaniyam, EK Waller, JR Murrow, A Manatunga, S Lonial, K Kasirajan, D Sutcliffe, W Harris, WR Taylor, RW Alexander, AA Quyyumi | 07/01/2009 |
Regulation of alloimmune responses by dendritic cell subsets. Experimental hematology |
S Lonial, C Torre, E David, W Harris, M Arellano, EK Waller | 10/01/2008 |
Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
KP Parker, DL Bliwise, M Ribeiro, SR Jain, CI Vena, MK Kohles-Baker, A Rogatko, Z Xu, WB Harris | 05/20/2008 |
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.